Brief: Taysha Gene Therapies reports Q2 results
11/08/2022 12:42
Aug 11 (Reuters) - Taysha Gene Therapies Inc TSHA.O :
* TAYSHA GENE THERAPIES REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* TAYSHA GENE THERAPIES INC - NET LOSS FOR THREE MONTHS
ENDED JUNE
30, 2022, WAS $33.9 MILLION, OR $0.84 PER SHARE
* TAYSHA GENE THERAPIES INC - CURRENT CASH RUNWAY IS
SUFFICIENT TO
FUND OPERATING EXPENSES INTO Q4 OF 2023
Source text for Eikon: ID:nGNX7VHxQj
Further company coverage: TSHA.O
Recent news on Taysha Gene Therapies
See all newsUniqure jumps after FDA vaccines chief Vinay Prasad to step down
US FDA names agency critic Vinay Prasad as top vaccine official (updated)
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
US FDA names oncologist Vinay Prasad as top vaccine official (updated)